Brown Advisory Inc. Sells 91,534 Shares of Phreesia, Inc. (NYSE:PHR)

Brown Advisory Inc. reduced its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 1.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,594,590 shares of the company's stock after selling 91,534 shares during the quarter. Brown Advisory Inc. owned approximately 9.63% of Phreesia worth $140,760,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Johnson Financial Group Inc. raised its holdings in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. R Squared Ltd purchased a new stake in Phreesia in the 4th quarter valued at about $30,000. BankPlus Trust Department bought a new position in shares of Phreesia during the 4th quarter worth approximately $34,000. Quarry LP boosted its stake in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after buying an additional 1,923 shares during the last quarter. Finally, Venturi Wealth Management LLC bought a new position in shares of Phreesia in the fourth quarter valued at approximately $76,000. 92.10% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. KeyCorp cut their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Citigroup boosted their price target on shares of Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a report on Friday, January 10th. Canaccord Genuity Group raised their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, March 13th. Piper Sandler reiterated an "overweight" rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Needham & Company LLC reissued a "buy" rating and set a $29.00 target price on shares of Phreesia in a research report on Thursday, March 13th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia presently has a consensus rating of "Buy" and a consensus target price of $31.33.

Phreesia Stock Performance

PHR stock traded up $0.50 during midday trading on Friday, reaching $25.88. 649,809 shares of the company's stock traded hands, compared to its average volume of 433,418. The firm has a market capitalization of $1.52 billion, a PE ratio of -17.61 and a beta of 0.74. The company has a 50-day moving average price of $25.08 and a two-hundred day moving average price of $24.64. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Insider Activity at Phreesia

In related news, insider Yvonne Hui sold 1,878 shares of the business's stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $44,790.30. Following the completion of the transaction, the insider now owns 28,449 shares of the company's stock, valued at approximately $678,508.65. The trade was a 6.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Balaji Gandhi sold 28,759 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total transaction of $862,770.00. Following the sale, the chief financial officer now directly owns 116,174 shares in the company, valued at $3,485,220. This trade represents a 19.84 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 111,640 shares of company stock worth $3,094,167. 5.80% of the stock is owned by company insiders.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.